Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

May 28, 2004

Primary Completion Date

May 4, 2005

Study Completion Date

May 4, 2005

Conditions
MenopauseMenopausal Vasomotor Symptoms
Interventions
DRUG

0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

One tablet per day for 24 weeks

DRUG

0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA)

One tablet per day for 24 weeks

DRUG

placebo

Placebo tablets for 24 weeks

Trial Locations (91)

1000

Novo Nordisk Investigational Site, Brussels

1170

Novo Nordisk Investigational Site, Watermael-Boifort

1180

Novo Nordisk Investigational Site, Brussels

1200

Novo Nordisk Investigational Site, Brussels

1410

Novo Nordisk Investigational Site, Kolbotn

1630

Novo Nordisk Investigational Site, Bulle

1713

Novo Nordisk Investigational Site, Grålum

2000

Novo Nordisk Investigational Site, Frederiksberg

Novo Nordisk Investigational Site, Lillestrøm

2400

Novo Nordisk Investigational Site, København N

2650

Novo Nordisk Investigational Site, Hvidovre

2830

Novo Nordisk Investigational Site, Virum

3000

Novo Nordisk Investigational Site, Leuven

3450

Novo Nordisk Investigational Site, Allerød Municipality

4000

Novo Nordisk Investigational Site, Liège

4088

Novo Nordisk Investigational Site, Stavanger

4500

Novo Nordisk Investigational Site, Huy

4700

Novo Nordisk Investigational Site, Næstved

5000

Novo Nordisk Investigational Site, Odense C

5231

Novo Nordisk Investigational Site, Paradis

6110

Novo Nordisk Investigational Site, Montigny-le-Tilleul

8000

Novo Nordisk Investigational Site, Århus C

8032

Novo Nordisk Investigational Site, Zurich

8091

Novo Nordisk Investigational Site, Zurich

8500

Novo Nordisk Investigational Site, Frauenfeld

8570

Novo Nordisk Investigational Site, Weinfelden

9000

Novo Nordisk Investigational Site, Ghent

11108

Novo Nordisk Investigational Site, Narbonne

13004

Novo Nordisk Investigational Site, Marseille

13385

Novo Nordisk Investigational Site, Marseille

20100

Novo Nordisk Investigational Site, Turku

30000

Novo Nordisk Investigational Site, Nîmes

31059

Novo Nordisk Investigational Site, Toulouse

33101

Novo Nordisk Investigational Site, Tampere

34000

Novo Nordisk Investigational Site, Montpellier

34295

Novo Nordisk Investigational Site, Montpellier

44093

Novo Nordisk Investigational Site, Nantes

48431

Novo Nordisk Investigational Site, Rheine

64653

Novo Nordisk Investigational Site, Lorsch

66333

Novo Nordisk Investigational Site, Völklingen

70563

Novo Nordisk Investigational Site, Stuttgart

72076

Novo Nordisk Investigational Site, Tübingen

73614

Novo Nordisk Investigational Site, Schorndorf

76199

Novo Nordisk Investigational Site, Karlsruhe

76287

Novo Nordisk Investigational Site, Rheinstetten

85295

Novo Nordisk Investigational Site, La Roche-sur-Yon

90100

Novo Nordisk Investigational Site, Oulu

A 1060

Novo Nordisk Investigational Site, Vienna

A 1090

Novo Nordisk Investigational Site, Vienna

02200

Novo Nordisk Investigational Site, Espoo

00100

Novo Nordisk Investigational Site, Helsinki

Unknown

Novo Nordisk Investigational Site, Amiens

06000

Novo Nordisk Investigational Site, Nice

06917

Novo Nordisk Investigational Site, Jessen

04207

Novo Nordisk Investigational Site, Leipzig

NO-2317

Novo Nordisk Investigational Site, Hamar

0309

Novo Nordisk Investigational Site, Oslo

NO-4011

Novo Nordisk Investigational Site, Stavanger

NO-7012

Novo Nordisk Investigational Site, Trondheim

411 19

Novo Nordisk Investigational Site, Gothenburg

416 85

Novo Nordisk Investigational Site, Gothenburg

581 85

Novo Nordisk Investigational Site, Linköping

582 22

Novo Nordisk Investigational Site, Linköping

221 85

Novo Nordisk Investigational Site, Lund

217 44

Novo Nordisk Investigational Site, Malmo

602 32

Novo Nordisk Investigational Site, Norrköping

751 85

Novo Nordisk Investigational Site, Uppsala

GU12 5BA

Novo Nordisk Investigational Site, Aldershot

TN39 4SP

Novo Nordisk Investigational Site, Bexhill-on-Sea

BE9'1 2JL

Novo Nordisk Investigational Site, Birmingham

BL1 6AF

Novo Nordisk Investigational Site, Bolton

S40 4AA

Novo Nordisk Investigational Site, Chesterfield, Derbyshire

SN15 1HP

Novo Nordisk Investigational Site, Chippenham

TR1 2LZ

Novo Nordisk Investigational Site, Cornwell

CV6 2FL

Novo Nordisk Investigational Site, Coventry

BH15 2JB

Novo Nordisk Investigational Site, Devon

TN34 3EY

Novo Nordisk Investigational Site, Hastings

HU2 8PX

Novo Nordisk Investigational Site, Hull

PE21 6PF

Novo Nordisk Investigational Site, Linclolshire

L8 7SS

Novo Nordisk Investigational Site, Liverpool

SE1 9RT

Novo Nordisk Investigational Site, London

SE5 8RS

Novo Nordisk Investigational Site, London

W12 0HS

Novo Nordisk Investigational Site, London

M13 0JH

Novo Nordisk Investigational Site, Manchester

NR4 7UZ

Novo Nordisk Investigational Site, Norfolk

OX3 9UD

Novo Nordisk Investigational Site, Oxford

RG7 3SQ

Novo Nordisk Investigational Site, Reading

S1 2PJ

Novo Nordisk Investigational Site, Sheffield

ST4 6QG

Novo Nordisk Investigational Site, Stoke-on-Trent

IP33 1HE

Novo Nordisk Investigational Site, Suffolk

HA1 3UJ

Novo Nordisk Investigational Site, Watford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00184795 - Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations | Biotech Hunter | Biotech Hunter